Zileuton, a new efficient and safe systemic anti-acne drug
about
Novel pharmacological approaches for the treatment of acne vulgarisRecent advances in the search for novel 5-lipoxygenase inhibitorsTreating acne with antibiotic-resistant bacterial colonization.Advances in iron chelation: an update.Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles.Comparing efficacy of Montelukast versus doxycycline in treatment of moderate acnePeroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions.The aetiopathogenesis of acne vulgaris - what's new?Management of severe acne.Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?A review of the role of sebum in the mechanism of acne pathogenesis.Anti-acne drugs in phase 1 and 2 clinical trials.Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors.Development and validation of a liquid chromatography-mass spectrometry method for the determination of zileuton in human plasma.[Pathophysiology of acne. What is confirmed?].RIS-1/psoriasin expression in epithelial skin cells indicates their selective role in innate immunity and in inflammatory skin diseases including acne.The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes
P2860
Q28241186-57E1B19C-6658-414A-983E-91F2D2DDF8A1Q28296738-48A643EB-23A2-471D-B5AF-19D514902879Q34167188-C898F200-919F-4177-85A0-C159BA23F02AQ34174307-0E9044FA-62AC-49E2-9CAD-2A7E93EA59CAQ34447995-942A3240-8A21-4379-AF60-BB97350F51ACQ35745309-6AC7A5EF-5B8A-480D-AC7F-689133B66C64Q37959975-8FA51AF7-E2AE-4176-8C5B-39F331D531B2Q38153454-8F627C2A-59F8-4455-A50D-6FE430D8C892Q38191671-A6B14115-4635-464D-ABBA-F22572AB5970Q38322352-B812C537-90E8-4311-9CA6-DA5D19B2C410Q38489705-996A2D2A-6CB8-448A-B2AF-92A24887CE75Q39337690-7D1F937D-0504-4C4F-93A9-A6B8837D4153Q39382177-ABB04A66-C4A6-49C3-A9B0-C94918BAA552Q39500070-3C73A58D-51F0-4ED8-98AD-1852B6731077Q43161742-B19FF8D0-DB64-45C3-A5E1-C4F29C357964Q43416357-91DFB5BA-F975-4C6A-B9E5-77780E1E09F8Q50293411-E478FC97-D19B-4374-82FB-91D19122A518Q58701571-28E543EF-02BA-4485-8030-96B53C0FE53E
P2860
Zileuton, a new efficient and safe systemic anti-acne drug
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Zileuton, a new efficient and safe systemic anti-acne drug
@ast
Zileuton, a new efficient and safe systemic anti-acne drug
@en
type
label
Zileuton, a new efficient and safe systemic anti-acne drug
@ast
Zileuton, a new efficient and safe systemic anti-acne drug
@en
prefLabel
Zileuton, a new efficient and safe systemic anti-acne drug
@ast
Zileuton, a new efficient and safe systemic anti-acne drug
@en
P2860
P356
P1476
Zileuton, a new efficient and safe systemic anti-acne drug
@en
P2093
Christos C Zouboulis
P2860
P304
P356
10.4161/DERM.1.3.8368
P577
2009-05-01T00:00:00Z